| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Monteagudo, María |
| dc.contributor.author | Calsina, Bruna |
| dc.contributor.author | Salazar Hidalgo, Milton |
| dc.contributor.author | Martinez Montes, Angel Mario |
| dc.contributor.author | Piñeiro-Yáñez, Elena |
| dc.contributor.author | Caleiras, Eduardo |
| dc.contributor.author | Lopez-Fernandez, Adrià |
| dc.date.accessioned | 2024-12-30T12:31:16Z |
| dc.date.available | 2024-12-30T12:31:16Z |
| dc.date.issued | 2024-12 |
| dc.identifier.citation | Monteagudo M, Calsina B, Salazar-Hidalgo ME, Martínez-Montes ÁM, Piñeiro-Yáñez E, Caleiras E, et al. MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma. Best Pract Res Clin Endocrinol Metab. 2024 Dec;38(6):101931. |
| dc.identifier.issn | 1521-690X |
| dc.identifier.uri | https://hdl.handle.net/11351/12363 |
| dc.description | Paraganglioma; Feocromocitoma; Microambiente tumoral |
| dc.language.iso | eng |
| dc.publisher | Elsevier |
| dc.relation.ispartofseries | Best Practice & Research Clinical Endocrinology & Metabolism;38(6) |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.source | Scientia |
| dc.subject | Tumors neuroendocrins - Aspectes genètics |
| dc.subject | Metàstasi |
| dc.subject | Tumors neuroendocrins - Tractament |
| dc.subject.mesh | Neuroendocrine Tumors |
| dc.subject.mesh | /genetics |
| dc.subject.mesh | Tumor Microenvironment |
| dc.subject.mesh | Neoplasm Metastasis |
| dc.title | MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1016/j.beem.2024.101931 |
| dc.subject.decs | tumores neuroendocrinos |
| dc.subject.decs | /genética |
| dc.subject.decs | microambiente tumoral |
| dc.subject.decs | metástasis neoplásica |
| dc.relation.publishversion | https://doi.org/10.1016/j.beem.2024.101931 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Monteagudo M] Hereditary Endocrine Cancer Group; Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain. PhD Program in Neuroscience, Universidad Autonoma de Madrid-Cajal Institute, Madrid, Spain. [Calsina B] Familial Cancer Clinical Unit, Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain. [Salazar-Hidalgo ME, Martínez-Montes ÁM] Hereditary Endocrine Cancer Group; Human Cancer Genetics Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain. [Piñeiro-Yáñez E] Bioinformatics Unit, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. [Caleiras E] Histopathology Core Unit Biotechnology Program Spanish National Cancer Research Centre (CNIO), Madrid, Spain. [López-Fernández A] Servei d’Oncologia Mèdica, Vall d′Hebron Hospital Universitari, Barcelona, Spain |
| dc.identifier.pmid | 39218714 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |